5UGG
 
 | | Protease Inhibitor | | 分子名称: | Nalpha-[trans-4-(aminomethyl)cyclohexane-1-carbonyl]-N-octyl-O-[(quinolin-2-yl)methyl]-L-tyrosinamide, Plasminogen | | 著者 | Law, R.H.P, Wu, G, Whisstock, J.C. | | 登録日 | 2017-01-08 | | 公開日 | 2017-05-31 | | 最終更新日 | 2020-01-08 | | 実験手法 | X-RAY DIFFRACTION (1.2 Å) | | 主引用文献 | X-ray crystal structure of plasmin with tranexamic acid-derived active site inhibitors.
Blood Adv, 1, 2017
|
|
5UGD
 | | Protease Inhibitor | | 分子名称: | Nalpha-[trans-4-(aminomethyl)cyclohexane-1-carbonyl]-N-octyl-O-[(pyridin-4-yl)methyl]-L-tyrosinamide, Plasminogen | | 著者 | Law, R.H.P, Wu, G, Whisstock, J.C. | | 登録日 | 2017-01-08 | | 公開日 | 2017-05-31 | | 最終更新日 | 2023-10-04 | | 実験手法 | X-RAY DIFFRACTION (1.38 Å) | | 主引用文献 | X-ray crystal structure of plasmin with tranexamic acid-derived active site inhibitors.
Blood Adv, 1, 2017
|
|
